MoneyBall Medicine

Health & Wellness Podcasts >

At MoneyBall Medicine, host Harry Glorikian talks with leaders in the healthcare and life sciences industry about the ongoing data-driven transformation of their industry. Having the right data and knowing how to use it will be the key to success in the healthcare market in the future. In drug development and precision medicine, better data is giving physicians new way to diagnose and treat patients. In hospital management and insurance, administrators and information technology directors are using data to bring down costs and create new value. In the world of devices, data and the AI algorithms that act on it are helping doctors do their jobs faster and with more accuracy. Following up on his 2017 book MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market, Harry turns to doctors, hospital administrators, IT directors, entrepreneurs, and others for help mapping out the changes taking place and gauging their impact on everyone from patients to researchers. Welcome to MoneyBall Medicine!

At MoneyBall Medicine, host Harry Glorikian talks with leaders in the healthcare and life sciences industry about the ongoing data-driven transformation of their industry. Having the right data and knowing how to use it will be the key to success in the healthcare market in the future. In drug development and precision medicine, better data is giving physicians new way to diagnose and treat patients. In hospital management and insurance, administrators and information technology directors are using data to bring down costs and create new value. In the world of devices, data and the AI algorithms that act on it are helping doctors do their jobs faster and with more accuracy. Following up on his 2017 book MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market, Harry turns to doctors, hospital administrators, IT directors, entrepreneurs, and others for help mapping out the changes taking place and gauging their impact on everyone from patients to researchers. Welcome to MoneyBall Medicine!

More Information

Location:

United States

Genres:

Health & Wellness Podcasts

Technology Podcasts

Business & Economics Podcasts

Description:

Twitter:

@hglorikian

Language:

English

Contact:

617-407-5093

Website:

http://www.glorikian.com

Email:

harry@glorikian.com

Episodes

Kevin Tabb of Beth Israel Lahey Health on How to Get Ahead of Change in Healthcare

8/9/2019

Harry talks with Kevin Tabb, MD, the CEO and president of Beth Israel Lahey Health, the product of Lahey Health's merger this spring with Beth Israel Deaconess Medical Center (BIDMC) and several other hospitals in the Boston region. How does Dr. Tabb manage change inside a growing organization that—by his own admission—has to build and implement new tools, processes and the actionable data it needs to evolve beyond the fee-for-service era. Dr. Tabb was CEO of BIDMC before the merger, and...

Duration:00:35:12

Peter Coffee and Salesforce's Vision for the Platformization of Healthcare

5/17/2019

Harry talks this week with Salesforce's vice president of strategic research, Peter Coffee. The computer-industry veteran and former tech columist says that in the era of 1) outcomes-based payments for medical care, 2) an aging patient base, and 3) ubiquitous sensors and continuous data collection, there's a huge opportunity—and financial incentive—for healthcare providers to employ technology platforms that improve the client experience. Might Salesforce end up marketing such a platform?...

Duration:00:44:56

Rhoda Au on Digital Biomarkers and Precision Brain Health

4/26/2019

As one of the researchers involved in the 70-year-long Framingham Heart Study, Rhoda Au is in a unique position to investigate whether changes in speech patterns in middle-aged people could prefigure the onset of Alzheimer’s disease later in life, and whether early detection might give patients more time to take preventative measures. She’s been part of the Framingham study since 1990, and she’s applying voice analysis software to 9,000 digital audio recordings of neuropsychological exams of...

Duration:00:39:35

Kathryn Teng on Unlocking the Puzzle of Population Health

4/12/2019

Kathryn Teng, MD, is division chief of internal medicine and community medicine at MetroHealth, one of three major healthcare systems serving Cleveland and the rest of Cuyahoga County in Ohio. She believes that healthcare costs are out of control in part because too many patients go directly to specialists about issues that their primary care physician or nurses could and should handle. But figuring out how many primary care doctors a big healthcare system like MetroHealth needs, and where...

Duration:00:39:22

Alán Aspuru-Guzik and the Revolution in Molecular Design

3/29/2019

Many of the processes carried out in traditional chemistry labs searching for new drugs or drug targets can be sped up through factory-style automation—and in fact, “combinatorial chemistry” was a big boost for the field. But Alán Aspuru-Guzik, a theoretical chemist in the departments of chemistry and computer science at the University of Toronto, says “the transition to autonomy is what we really want.” Think of a “self-driving chemical lab” that uses big data, AI, and robotics to explore...

Duration:00:30:52

Jennifer Carter and the Power of Individualized Cancer Care

3/15/2019

Dr. Jennifer Carter says it was watching friends and family members stricken with cancer struggle navigate the complexities of the healthcare system in the early 2000s that inspired her to start a company in the area of precision medicine. At that time, the development of targeted therapies for cancers with specific genetic markers was already offering new hope to patients, but it was also creating new challenges for doctors and patients, who had to digest, manage, and interpret...

Duration:00:42:20

Mark Boguski on Antidotes to Overspecialization in Medicine

3/1/2019

Adjusting to a more collaborative style may take doctors some time, says Dr. Mark Boguski, but if they stop confining themselves to disciplinary boundaries, they'll be able to see connections between different areas of medicine that aren't taught in medical schools. Boguski draws on examples from oncology, where he says doctors are gradually being retrained to think in terms of disease pathways instead of discreet organ systems. Dr. Boguski is the chief medical officer of Liberty...

Duration:00:37:47

Sandy Aronson on AI and Gene-based Personalized Medicine (AI World Special Series Part 2)

2/15/2019

Harry's guest Sandy Aronson argues that AI and apps are not the solution for better healthcare; more effective care workflows enabled by AI and apps are the solution. Aronson is the executive director of information technology at Partners HealthCare Personalized Medicine. His team develops the IT infrastructure needed to support genetic-based personalized medicine in both patient-based and laboratory settings. This episode is the second in a two-part series on getting AI, machine learning,...

Duration:00:41:48

Aalpen Patel and Using AI to Reduce Time-to-Diagnosis (AI World Special Series Part 1)

2/15/2019

What if we could use machine learning to train software to read CT scans of patients with intracranial hemorrhaging? Time to diagnosis could be doubled, potentially saving lives. This week Harry discusses such questions with Dr. Aalpen Patel, a physician-engineer who chairs Geisinger's department of radiology and directs is 3D imaging and printing laboratory. This episode is the first in a two-part series on getting AI, machine learning, and analytics working in the healthcare provider...

Duration:00:34:36

Massimo Buscema on AI and What We Can and Can't See in the Human Body

2/1/2019

Harry's guest in this episode is Massimo Buscema, director of the Semieon Research Center in Rome, Italy, and a full professor at the University of Colorado at Denver. Buscema researches and consults internationally on the theory and applications of AI, artificial neural networks, and evolutionary algorithms. The conversation focuses on AI and its applications in healthcare, and how it can enhance what we can see and uncover what we cannot. You can read a full transcript of this episode and...

Duration:00:37:00

Barrett Rollins and the DNA-driven Transformation of Oncology

1/18/2019

Harry's guest for this episode is Dr. Barrett Rollins, the chief scientific officer and faculty dean for academic affairs at Boston's Dana Farber Cancer Institute and the Linde Family Professor of Medicine at Harvard Medical School. Harry and Dr. Rollins dig into how large-scale DNA analysis can one day put much more usable information into the hands of oncologists, and how that data affects individual patients, the practice of medicine, and new therapies under development. How to rate...

Duration:00:30:08

Joel Dudley and What Happens When You Let Data—Not Hypotheses—Drive Discovery

1/4/2019

Harry's guest this week is Dr. Joel Dudley from the Icahn School of Medicine at Mount Sinai, where he serves as executive vice president of precision health, associate professor of genetics and genomic sciences, and founding director of the Institute for Next Generation Healthcare. Dr. Dudley explains how his group is utilizing data to uncover health problems that can't be detected through normal methods, as well as his groundbreaking paper on the link between Alzheimer's disease and...

Duration:00:29:00

Wim Van Hecke on Using AI to Quantify Changes in the Brain

12/18/2018

Harry talks with Wim Van Hecke, the founder and CEO of Icometrix—builder of a cloud-based AI platform for analyzing brain MRI and CT scans—to find out how the startup's FDA-cleared technology is changing the way radiologists and other physicians interpret neuroimaging data. How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod touch:

Duration:00:32:41

Robert Green on the Impact of Individual Genomic Data

12/7/2018

Harry's guest this week, Dr. Robert Green, is a professor of medicine and genetics at Harvard Medical School and director of the Genomes To People research program at Brigham & Women's Hospital and the Broad Institute of Harvard and MIT. They dig into the individual genome, how genomic data is being used, and the impact of genomics on various stakeholders in the healthcare system. How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod touch:

Duration:00:37:07

Sharon Terry on Changes in Drug Discovery, Diagnostics, and the Treatment of Patients

11/23/2018

Harry talks with Sharon Terry, president and CEO of Genetic Alliance, about the way drug discovery, diagnostics , and the treatment of patience are changing. How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod touch:

Duration:00:33:47

Fabien Beckers on AI and the Future of Medical Imaging

11/16/2018

Today's radiologists face a deluge of data, and their work can be tedious and error-prone. But should humans even act as radiologists? It's becoming clear that computers and humans working together are better than either alone. Harry's guest this week is Fabien Beckers, CEO of Arterys, a startup creating products at the intersection of AI, the cloud, and medical imaging. Beckers has led the growth of Arterys from four co-founders to a team of 100 today, as the company brings the first...

Duration:00:28:34

Wout Brusselaers: Every Patient in a Clinical Trial: How AI Can Solve One of Healthcare's Biggest (and Most Expensive) Problems (AI Biopharma Special Series Part 6)

11/14/2018

Harry speaks with Wout Brusselaers, CEO and founder of Deep6.AI, about new technology that could help find patients for clinical trials in minutes rather than months. This is Part 6 of a six-part special series recorded at the AI Applications Summit, produced in Boston by Corey Lane Partners in October 2018. How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod touch:

Duration:00:32:46

Guido Lanza: Can AI Prevent Failure in Drug Discovery Pipelines? (AI Biopharma Special Series Episode 5)

11/14/2018

Harry's guest is Guido Lanza, president and CEO of Numerate. Together they tackle the question: What if the introduction of AI into drug discovery allowed us to create a true learning loop? This is Part 5 of a special six-part series recorded at the AI Applications Summit, produced in Boston by Corey Lane Partners in October 2018. How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod touch:

Duration:00:39:11

Ron Alfa: To Reimagine Drug Discovery & Development, Let the Data Drive the Process (AI Biopharma Special Series Part 4)

11/14/2018

Harry asks Dr. Ron Alfa, vice president of discovery and product at Recursion Pharmaceuticals, what efficiencies could be achieved and what problems could be solved if data science were applied to drug discovery. This is Part 4 of a special six-part series recorded at the AI Applications Summit, produced in Boston by Corey Lane Partners in October 2018. How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod touch:

Duration:00:16:50

Shrujal Baxi: Is AI Ready to Solve Healthcare's Real-World Evidence Problem? (AI Biopharma Special Series Part 3)

11/14/2018

Harry's guest is Dr. Shrujal Baxi, medical director of Flatiron Health. On the agenda: how technology can help create the real-world evidence needed to achieve better patient outcomes and accelerate research into new areas. This is Part 3 of a 6-part special series recorded at the AI Applications Summit, produced in Boston by Corey Lane Partners in October 2018. How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod touch:

Duration:00:23:17